Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1997015561) CHIRAL METHYL PHENYL OXAZOLIDINONES
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1997/015561 International Application No.: PCT/DE1996/000259
Publication Date: 01.05.1997 International Filing Date: 09.02.1996
Chapter 2 Demand Filed: 04.04.1997
IPC:
C07D 263/24 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
263
Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
02
not condensed with other rings
08
having one double bond between ring members or between a ring member and a non-ring member
16
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
18
Oxygen atoms
20
attached in position 2
24
with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
Applicants:
SCHERING AKTIENGESELLSCHAFT [DE/DE]; Müllerstrasse 178 D-13353 Berlin, DE
Inventors:
LAURENT, Henry; DE
OTTOW, Eckhard; DE
KIRSCH, Gerald; DE
WACHTEL, Helmut; DE
SCHNEIDER, Herbert; DE
FAULDS, Daryl; US
DINTER, Harald; US
Priority Data:
195 40 475.020.10.1995DE
Title (DE) CHIRALE METHYLPHENYLOXAZOLIDINONE
(EN) CHIRAL METHYL PHENYL OXAZOLIDINONES
(FR) METHYLPHENYLOXAZOLIDINONES CHIRALES
Abstract:
(DE) (R)-(-)-Methylphenyloxazolidinon-Derivate der Formel (I), deren Herstellung und Verwendung in Arzneimitteln werden beschrieben, worin R einen Kohlenwasserstoffrest mit bis zu 5 C-Atomen bedeutet.
(EN) The invention relates to (R)-(-)- methyl phenyl oxazolidinone derivatives of formula (I), and the preparation and use thereof in drugs, formula in which R is a hydrocarbon radical with up to 5 C-atoms.
(FR) L'invention concerne des dérivés de (R)-(-)-méthylphényloxazolidinones de la formule (I) où R représente un reste hydrocarbure avec 5 atomes de carbone maximum. L'invention concerne également leur production et leur utilisation dans la composition de médicaments.
Designated States: AU, CA, CN, CZ, FI, HU, JP, KR, MX, NO, NZ, PL, RU, SK, TR
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: German (DE)
Filing Language: German (DE)
Also published as:
CZPV1998-1201FI980862NO19981688SK49598TR1998/00679MXPA/a/1998/002940
ZA1996/01074ES2158284EP0859766RU02156243US6025376JPH11513693
CN1200115CA2235264PT859766KR1019990064339NZ301645AU1996047123